#Ireland #Dublin #Lenire #Neuromod Devices #Joe Ghiz

Neuromod Devices Expands Leadership Team with Senior Appointments

On October 1, 2026, Neuromod Devices announced a significant boost to its leadership team, appointing Joe Ghiz as the Chief Commercial Officer (CCO) and Shannon Basham as the Vice President of Channel Development. These strategic hires come at a crucial phase for the company as it strives to enhance the lives of the 740 million people suffering from tinnitus globally through its groundbreaking treatment device, Lenire.

Introducing Joe Ghiz: A Key Player in Commercial Strategy

Joe Ghiz joins Neuromod with extensive experience from his previous roles at Align Technology, the creator of Invisalign, and Johnson & Johnson. With a rich background in leading commercial functions at these prominent companies, Ghiz is poised to play a pivotal role in Neuromod's ambitions to redefine tinnitus care.

Dr. Ross O'Neill, CEO of Neuromod, expressed enthusiasm about Ghiz's appointment, stating, "Joe's experience is invaluable at this time, as Neuromod seeks to scale up and make Lenire a new standard of care in tinnitus treatment. His strategic approach will cater to both clinicians and patients, ensuring that our revolutionary technology reaches those in need."

During his tenure at Align Technology, Ghiz was instrumental in the transformation of orthodontic practices through innovative commercial strategies that accelerated market growth and improved patient access. His track record in establishing new treatment models aligns perfectly with Neuromod's objectives.

In his own words, Ghiz said, "Joining Neuromod at this transformative time excites me. Lenire has already changed thousands of lives, and I believe we can extend its benefits to millions more."

Shannon Basham: Strengthening Channel Development

Joining Ghiz is Shannon Basham, who takes on the important role of VP of Channel Development. With over two decades of experience in the hearing care industry, Basham previously served as the Senior Director of Audiology at Sonova Group in the United States. Under her leadership, she significantly shaped the clinical and educational strategies of leading brands like Phonak and Unitron.

Basham brings a wealth of knowledge in the realm of audiology education, which is vital for Neuromod as it seeks to enhance the knowledge surrounding Lenire and its uses. Dr. O'Neill noted, "Shannon's profound expertise in the audiology space will be crucial in developing channels that facilitate better access to our innovative treatments."

Basham echoed her commitment, stating, "I am eager to leverage my experience in the hearing care industry to support Neuromod in its mission to ensure that patients have access to life-changing treatment options like Lenire."

About Neuromod and Lenire

Neuromod Devices is a leading medical technology firm specializing in neuromodulation therapies, particularly for tinnitus. The company's flagship product, Lenire, is the first non-invasive bimodal neuromodulation device, designed to offer effective treatment by combining audio stimulation with surface stimulation via a device called Tonguetip®. This innovative treatment has undergone extensive clinical validation and has received CE-mark certification along with de novo approval from the US FDA.

The combination of Ghiz’s and Basham’s expertise aims to propel Neuromod's growth further, expanding its market presence in the United States, Canada, Europe, and Australia. As the company expands, it remains committed to alleviating the suffering caused by tinnitus, making Lenire accessible to those in need.

For further details on Neuromod's advancements and product offerings, visit www.neuromod.com.

Conclusion

The recent appointments of Joe Ghiz and Shannon Basham mark a significant step in Neuromod’s journey to revolutionize how tinnitus is treated. By combining their extensive experience and knowledge, Neuromod aims not only to grow its commercial reach but also to improve the quality of life for tinnitus patients around the world.